3D MEDICINES(01244.HK):有意於市場上進行股份購回
格隆匯10月4日丨3D MEDICINES(01244.HK)發佈公吿,董事會已批准一項計劃,以行使公司股東在股東周年大會上授予董事會股份回購授權,以及將在適當時間在公開市場上提議和批准的回購公司股份的相關一般授權。根據股份回購授權,公司獲准回購最多2560.57萬股股份,佔公司於股東周年大會當日已發行股份總數的10%。截至本公吿日期,尚未根據股份回購授權回購和註銷股份。擬購股份計劃的批准期限自本公吿之日起不超過12個月。
董事會認為,股份的當前交易價格並不反映其內在價值及公司的實際業務前景。董事會認為,建議的股份回購計劃及其後取消已購股份可提高股份的價值,從而提高股東回報。董事會認為,建議的股份回購計劃符合公司及股東的整體利益。公司謹此感謝股東及投資者對公司的持續支持。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.